others show minimal response regardless of dose adjustment
It reflects real concern about how quickly this trend has spread and how little people understand about what they're actually doing to their bodies, a pattern we see with a lot of the skin cancer misconceptions circulating right now
GLP-1s are not currently approved by the FDA for people with type 1 diabetes due to concerns around risks for hypoglycemia and diabetic ketoacidosis (DKA)
Create Serious Penalties for Violations Fine pharmacies up to $1,000 per dose for drugs deemed improperly compounded Allow immediate license revocation Require warning labels stating the drug is not FDA-approved and may have known and unknown risks Whats worse is that some of these bills dont just target GLP-1s, they target all compounding
Features like metabolic measurements , body composition percentages , and medication half-life calculations provide valuable insights, but they also require a baseline knowledge for proper understanding
This is particularly common if alcohol is consumed in large amounts